在感染期间,mTORC1通路的葡萄糖皮质体调节调节了CD4+T细胞的反应
Huihui Chen1,2, Zhiwen Liu3,4, Jie Zha3,4
1Department of Ophthalmology the Second Xiangya Hospital of Central South University Changsha China.
葡萄糖皮质体 (GCs) 影响CD4+T细胞,增加感染风险. 这项研究揭示了GC通过mTORC1途径改变T调节细胞,在GC治疗期间提供恢复免疫功能的标.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的葡萄糖皮质体 (GC) 治疗可以抑制CD4+T细胞功能,增加对机会性感染的易感性.
- 了解CD4+T细胞中GC诱导的免疫调节的精确机制对于减轻不良影响至关重要.
研究的目的:
- 为了研究GC如何调节感染期间的CD4+T细胞功能.
- 阐明拉巴素复合体1 (mTORC1) 途径机械性标在GC介导对CD4+ T细胞影响中的作用.
主要方法:
- 从接受GC治疗的患者的CD4+T细胞中测量FOXP3,炎症性细胞因子和-S6核糖体蛋白.
- 使用Foxp3EGFP记者小鼠动态评估mTORC1通路激活及其与GC影响下的CD4+T细胞功能相关性.
主要成果:
- 通过改变FOXP3表达,GCs在CD4+T细胞中诱导了T调节 (Treg) 细胞表型.
- GCs损害了mTORC1通路的动力学,这与CD4+T细胞表型和功能的变化相关.
- 针对mTORC1通路调节了CD4+T细胞的GC受损的免疫调节能力,增强了Treg细胞的功能.
结论:
- 一种新的mTORC1介导机制在传统的GC治疗期间有助于CD4+T细胞免疫反应.
- 调节mTORC1通路代表了一种潜在的治疗策略,以恢复GC疗法损害的免疫功能.
更多相关视频
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
11:50Retroviral Transduction of Helper T Cells as a Genetic Approach to Study Mechanisms Controlling their Differentiation and Function
Published on: November 4, 2016
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
PI3K/mTOR/AKT Signaling Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Mitogens and the Cell Cycle
